Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q86TM3 (
cage
)
29,987
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Timely stalling and resumption of RNA polymerases at damaged chromatin are actively regulated processes. Prior work showed an importance of FACT histone chaperone in such process. Here we provide a new role of
OTUD5
deubiquitinase in the FACT-dependent process. Through a DUB RNAi screen, we found
OTUD5
as a specific stabilizer of the UBR5 E3 ligase.
OTUD5
localizes to DNA double strand breaks (DSBs), interacts with UBR5 and represses the RNA Pol II elongation and RNA synthesis.
OTUD5
co-localizes and interacts with the FACT component SPT16 and antagonizes the histone H2A deposition at DSB lesions.
OTUD5
interacts with UBR5 and SPT16 independently through two distinct regions, and both interactions are necessary for arresting the Pol II elongation at lesions. These analyses suggested that the catalytic (through UBR5 stabilization) as well as scaffolding (through FACT binding) activities of
OTUD5
are involved in the FACT-dependent transcription. We found that a
cancer-associated
missense mutation within the
OTUD5
Ubiquitin Interacting Motif (UIM) abrogates the FACT association and the Pol II arrest, providing a possible link between the transcriptional regulation and tumor suppression. Our work establishes
OTUD5
as a new regulator of the DNA damage response, and provides an insight into the FACT-dependent transcription at damaged chromatin.
...
PMID:The OTUD5-UBR5 complex regulates FACT-mediated transcription at damaged chromatin. 3050 13